Once-daily single-tablet regimens: a long and winding road to excellence in antiretroviral treatment.
about
Dolutegravir: clinical efficacy and role in HIV therapy.Recent trends in early stage response to combination antiretroviral therapy in Australia.Focal bone lesions in HIV-positive patient treated with tenofovirCharacterization of treatment failure in HIV positive patients in the Colombian Caribbean region.Patient-Reported Outcomes After a Switch to a Single-Tablet Regimen of Rilpivirine, Emtricitabine, and Tenofovir DF in HIV-1-Positive, Virologically Suppressed Individuals: Additional Findings From a Randomized, Open-Label, 48-Week TrialIncrease in single-tablet regimen use and associated improvements in adherence-related outcomes in HIV-infected women.
P2860
Once-daily single-tablet regimens: a long and winding road to excellence in antiretroviral treatment.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Once-daily single-tablet regim ...... e in antiretroviral treatment.
@en
type
label
Once-daily single-tablet regim ...... e in antiretroviral treatment.
@en
prefLabel
Once-daily single-tablet regim ...... e in antiretroviral treatment.
@en
P1433
P1476
Once-daily single-tablet regim ...... ce in antiretroviral treatment
@en
P2093
Bonaventura Clotet
Josep M Llibre
P304
P577
2012-07-01T00:00:00Z